Literature DB >> 10976505

New aromatic iminoimidazolidine derivatives as alpha1-adrenoceptor antagonists: a novel synthetic approach and pharmacological activity.

C Dardonville1, P Goya, I Rozas, A Alsasua, M I Martín, M J Borrego.   

Abstract

The design, synthesis and alpha1-adrenoceptor antagonism of a series of bis-imidazoline (1a, 2a, 3a and 4a) and bis-guanidine (1b, 2b, 3b and 4b) diphenyl derivatives are reported. All of these compounds fulfill the conditions of the most recent pharmacophore proposed for alpha1-adrenoceptors and found in the literature. Besides, a novel synthetic approach to the preparation of 2-(arylimino)imidazolidine derivatives is described. All the tested compounds, except the bis-guanidinium derivative 3b, inhibit the contractile responses induced by noradrenaline in aortic rings of rat and rabbit in a dose-dependent manner. Our results indicate that, even though some discrepancies are observed in terms of the alpha1 subtype targeted by this new family of compounds, they show an interesting profile as antagonists of alpha1-adrenoceptors and a new prototype, compound 1a, has been found deserving further development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976505     DOI: 10.1016/s0968-0896(00)00089-4

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Understanding the DNA binding of novel non-symmetrical guanidinium/2-aminoimidazolinium derivatives.

Authors:  Padraic S Nagle; Susan J Quinn; John M Kelly; Daniel H O'Donovan; Amir R Khan; Fernando Rodriguez; Binh Nguyen; W David Wilson; Isabel Rozas
Journal:  Org Biomol Chem       Date:  2010-10-15       Impact factor: 3.876

2.  Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid.

Authors:  Lei Wang; Martha Sibrian-Vazquez; Jorge O Escobedo; Jialu Wang; Richard G Moore; Robert M Strongin
Journal:  Chem Commun (Camb)       Date:  2015-01-31       Impact factor: 6.222

3.  Exploring the Anti-Cancer Mechanism of Novel 3,4'-Substituted Diaryl Guanidinium Derivatives.

Authors:  Viola Previtali; Helene B Mihigo; Rebecca Amet; Anthony M McElligott; Daniela M Zisterer; Isabel Rozas
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-21

4.  Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure-Activity Relationship Studies.

Authors:  David Cisneros; Eduardo J Cueto-Díaz; Tania Medina-Gil; Rebecca Chevillard; Teresa Bernal-Fraile; Ramón López-Sastre; Mustafa M Aldfer; Marzuq A Ungogo; Hamza A A Elati; Natsumi Arai; Momoka Otani; Shun Matsushiro; Chiaki Kojima; Godwin U Ebiloma; Tomoo Shiba; Harry P de Koning; Christophe Dardonville
Journal:  ACS Med Chem Lett       Date:  2022-01-28       Impact factor: 4.345

5.  In and out of the minor groove: interaction of an AT-rich DNA with the drug CD27.

Authors:  Francisco J Acosta-Reyes; Christophe Dardonville; Harry P de Koning; Manal Natto; Juan A Subirana; J Lourdes Campos
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-24

Review 6.  Ligands with Two Monoanionic N,N-Binding Sites: Synthesis and Coordination Chemistry.

Authors:  Robert Kretschmer
Journal:  Chemistry       Date:  2019-11-22       Impact factor: 5.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.